Is DermaPrime a medical device?

DermaPrime is currently research-use software. We are pursuing CE-marking (MDR Class IIa) and FDA pathway in parallel. Outputs are decision-support and do not replace clinical diagnosis.

How is the depth prediction module trained?

Our DermaDepth model is trained on paired dermoscopic images and corresponding histopathological Breslow depth measurements, with regression heads calibrated on multi-site cohorts.

What about patient data privacy?

DermaPrime is built HIPAA- and GDPR-aligned. All images are encrypted at rest and in transit. De-identification is applied before any research use.

Can clinics integrate DermaPrime with their EHR?

Yes. Enterprise plans include REST APIs, FHIR integration roadmap and white-label deployments for hospital networks.

DermaPrime — AI Skin Intelligence Platform

See skin cancer earlier.
Monitor every lesion.
Estimate depth, non-invasively.

DermaPrime is the AI Skin Intelligence Platform combining lesion classification, longitudinal monitoring and the world's first non-invasive melanoma depth prediction module — built for patients, dermatologists and research clinics.

iPhone & phone photo analysis — assesses 140+ skin conditions

95%

Accuracy · ISIC dataset*

±0.18mm

Depth MAE*

140+

Skin conditions · from phone photo

*Tested on the ISIC dataset — achieved 95% accuracy on the held-out validation set. Pending external clinical validation.

Module 1 · Classification

Lesion Classification

An 8-class dermatology taxonomy that distinguishes melanoma, basal cell carcinoma, squamous cell carcinoma, actinic keratosis, benign nevi, seborrheic keratosis, vascular lesions and dermatofibromas — with calibrated confidence and a top-3 differential.

Works on both dermoscopic and smartphone images (140+ skin conditions covered)
Top-3 differential diagnoses with probability bars
Temperature-calibrated confidence — no over-confident outputs
Built-in 'not skin' detector rejects non-clinical photos

95%

Accuracy · ISIC validation set

8 + 140

Cancer classes · skin conditions

Module 2 · Longitudinal Monitoring

Longitudinal Monitoring

Track every lesion over time. DermaPrime aligns serial photos of the same site, scores ABCDE evolution and surfaces meaningful change before it becomes urgent.

Side-by-side timeline of every scan per lesion entry
AI-driven change detection: size, border, color, new features
Automatic progression alerts (improving / stable / worsening)
Reminders, body-area tagging and personal notes per entry

1 in 5

People develop skin cancer

Δ ABCDE

Quantified between scans

Module 3 · Depth Prediction

Melanoma Depth Prediction

DermaPrime's flagship innovation: a non-invasive Breslow-depth estimate from a single dermoscopic image — the prognostic factor that historically required excision and histopathology.

Continuous depth regression (mm) with uncertainty range
Visual depth heatmap highlighting deeper pigmented regions
Risk stratification aligned with AJCC T1a / T1b / T2+ thresholds
Decision-support only — never replaces histopathological diagnosis

±0.18 mm

Depth MAE (research)

T1–T4

AJCC stage mapping

Module 4 · Explainable AI

Explainable AI

Every prediction comes with a visual and textual rationale. Clinicians and patients can see exactly which regions and dermoscopic features drove the model's decision.

GradCAM-style attention heatmaps overlaid on the original photo
Plain-language explanation of the visible dermoscopic features
ABCDE breakdown with per-axis scores 0–10 and rationale
Auditable trail — every score, feature and probability is stored per scan

100%

Predictions with rationale

5 axes

ABCDE quantified per scan

Non-invasive Breslow depth prediction

A dedicated deep-learning module estimates melanoma invasion depth directly from a dermoscopic image — providing clinicians with crucial pre-biopsy staging information that historically required excision.

Continuous depth regression with calibrated confidence intervals

Visual heatmap of depth-contributing regions

Risk stratification aligned with AJCC staging (T1a / T1b / T2+)

Designed for prospective clinical validation studies

See skin cancer earlier.Monitor every lesion. Estimate depth, non-invasively.

Learn before you scan

Real stories. Real skin. Real science.

Six skin cancers worth recognising

Most moles are harmless. A few aren't.

Your skin tells a bigger story